129 related articles for article (PubMed ID: 37455552)
1. Association between serum uric acid and prostate cancer mortality in androgen deprivation therapy: A population-based cohort study.
Lee YHA; Chan JSK; Leung CH; Hui JMH; Dee EC; Ng K; Liu K; Liu T; Tse G; Ng CF
Cancer Med; 2023 Aug; 12(16):17056-17060. PubMed ID: 37455552
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study.
Lee YHA; Hui JMH; Chan JSK; Liu K; Dee EC; Ng K; Tang P; Tse G; Ng CF
Prostate; 2023 Jan; 83(1):119-127. PubMed ID: 36178848
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study.
Chan JSK; Satti DI; Lee YHA; Hui JMH; Dee EC; Ng K; Liu K; Tse G; Ng CF
Br J Cancer; 2023 Jun; 128(12):2253-2260. PubMed ID: 37076564
[TBL] [Abstract][Full Text] [Related]
4. Metformin use and hospital attendance-related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population-based cohort study.
Lee YHA; Hui JMH; Chung CT; Liu K; Dee EC; Ng K; Tse G; Chan JSK; Ng CF
Cancer Med; 2023 Apr; 12(8):9128-9132. PubMed ID: 36734312
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic impact of cardiovascular comorbidities in patients with prostate cancer receiving androgen deprivation therapy: A population-based competing risk analysis.
Chan JSK; Lee YHA; Hui JMH; Liu K; Dee EC; Ng K; Liu T; Tse G; Ng CF
Int J Cancer; 2023 Aug; 153(4):756-764. PubMed ID: 37183319
[TBL] [Abstract][Full Text] [Related]
6. HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy.
Chan JSK; Lee YHA; Liu K; Hui JMH; Dee EC; Ng K; Satti DI; Liu T; Tse G; Ng CF
Eur Urol Open Sci; 2023 Jan; 47():3-11. PubMed ID: 36601042
[TBL] [Abstract][Full Text] [Related]
7. Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population-based cohort study.
Lee YHA; Chan JSK; Hui JMH; Tang P; Liu K; Dee EC; Ng K; Tse G; Ng CF
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38140773
[TBL] [Abstract][Full Text] [Related]
8. Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan.
Huang WK; Liu CH; Pang ST; Liu JR; Chang JW; Liaw CC; Hsu CL; Lin YC; See LC
JAMA Netw Open; 2020 Aug; 3(8):e2015189. PubMed ID: 32865575
[TBL] [Abstract][Full Text] [Related]
9. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
Tully KH; Nguyen DD; Herzog P; Jin G; Noldus J; Nguyen PL; Kibel AS; Sun M; McGregor B; Basaria S; Trinh QD
Eur Urol Oncol; 2021 Feb; 4(1):66-72. PubMed ID: 31624049
[TBL] [Abstract][Full Text] [Related]
10. Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer.
Forster RB; Engeland A; Kvåle R; Hjellvik V; Bjørge T
Int J Cancer; 2022 Oct; 151(7):1109-1119. PubMed ID: 35489025
[TBL] [Abstract][Full Text] [Related]
11. Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real-world evidence study.
Liu JM; Wu CT; Hsu RJ; Hsu WL
Cancer Med; 2021 Nov; 10(22):8162-8171. PubMed ID: 34590436
[TBL] [Abstract][Full Text] [Related]
12. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.
Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH
JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269
[TBL] [Abstract][Full Text] [Related]
13. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
[TBL] [Abstract][Full Text] [Related]
14. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
[TBL] [Abstract][Full Text] [Related]
15. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
Schmidt AL; Tucker MD; Bakouny Z; Labaki C; Hsu CY; Shyr Y; Armstrong AJ; Beer TM; Bijjula RR; Bilen MA; Connell CF; Dawsey SJ; Faller B; Gao X; Gartrell BA; Gill D; Gulati S; Halabi S; Hwang C; Joshi M; Khaki AR; Menon H; Morris MJ; Puc M; Russell KB; Shah NJ; Sharifi N; Shaya J; Schweizer MT; Steinharter J; Wulff-Burchfield EM; Xu W; Zhu J; Mishra S; Grivas P; Rini BI; Warner JL; Zhang T; Choueiri TK; Gupta S; McKay RR
JAMA Netw Open; 2021 Nov; 4(11):e2134330. PubMed ID: 34767021
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
Shah NJ; Patel VG; Zhong X; Pina L; Hawley JE; Lin E; Gartrell BA; Febles VA; Wise DR; Qin Q; Mellgard G; Joshi H; Nauseef JT; Green DA; Vlachostergios PJ; Kwon DH; Huang F; Liaw B; Tagawa S; Kantoff P; Morris MJ; Oh WK
JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35657341
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases.
Liu JM; Chen YT; Wu CT; Hsu WL; Hsu RJ
Prostate; 2022 May; 82(7):809-815. PubMed ID: 35226371
[TBL] [Abstract][Full Text] [Related]
18. Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort study.
Wong C; Chu P; Teoh J; Chiu P; Yee CH; Chau L; Chan M; Wan H; Leung S; Ng CF
Int Urol Nephrol; 2022 May; 54(5):993-1000. PubMed ID: 35217907
[TBL] [Abstract][Full Text] [Related]
19. Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged ≥66 years.
Abdollah F; Sammon JD; Reznor G; Sood A; Schmid M; Klett DE; Sun M; Aizer AA; Choueiri TK; Hu JC; Kim SP; Kibel AS; Nguyen PL; Menon M; Trinh QD
Eur J Surg Oncol; 2015 Nov; 41(11):1529-39. PubMed ID: 26210655
[TBL] [Abstract][Full Text] [Related]
20.
Smile TD; Tom MC; Halima A; Ciezki JP; Reddy CA; Stephans KL; Mian OY; Zhang RX; Klein EA; Campbell S; Ulchaker J; Angermeier K K; Tendulkar RD
Brachytherapy; 2022; 21(1):85-93. PubMed ID: 34656435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
